Analgesics (Pharmacies) - Northern Africa

  • Northern Africa
  • Revenue in the Analgesics market is projected to reach US$0.57bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.54%, resulting in a market volume of US$0.82bn by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.18 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Northern Africa is experiencing significant growth, driven by various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Analgesics (Pharmacies) market in Northern Africa are shifting towards a preference for over-the-counter (OTC) analgesics. This can be attributed to the convenience and accessibility offered by OTC products, as they can be purchased without a prescription and are readily available in pharmacies. Additionally, customers are increasingly seeking analgesics that provide quick and effective relief from pain, leading to a rise in demand for fast-acting and long-lasting pain relief medications. Trends in the market indicate a growing demand for natural and herbal analgesics in Northern Africa. Customers are becoming more conscious about the ingredients and potential side effects of pharmaceutical drugs, leading them to opt for natural alternatives. This trend is driven by a desire for holistic and sustainable healthcare solutions. As a result, the market is witnessing an increase in the availability and variety of natural analgesic products, including herbal remedies and traditional medicines. Local special circumstances in Northern Africa, such as a high prevalence of chronic pain conditions and an aging population, are contributing to the growth of the Analgesics (Pharmacies) market. Chronic pain conditions, such as arthritis and back pain, are common in the region, leading to a higher demand for analgesics. Furthermore, the aging population in Northern Africa is more susceptible to pain-related ailments, creating a continuous need for analgesic medications. Underlying macroeconomic factors, such as increasing disposable incomes and improving healthcare infrastructure, are also driving the growth of the Analgesics (Pharmacies) market in Northern Africa. Rising incomes allow individuals to afford better quality healthcare, including analgesics. Moreover, the improvement in healthcare infrastructure, including the expansion of pharmacies and the availability of a wider range of analgesic products, has made it easier for customers to access and purchase these medications. In conclusion, the Analgesics (Pharmacies) market in Northern Africa is developing due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customers are increasingly opting for OTC analgesics and natural remedies, driven by convenience, effectiveness, and a desire for holistic healthcare solutions. Local special circumstances, such as a high prevalence of chronic pain conditions and an aging population, contribute to the growth of the market. Additionally, improving disposable incomes and healthcare infrastructure support the expansion of the Analgesics (Pharmacies) market in Northern Africa.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)